Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
BMC Chemistry|August 27, 2024
Fused in silico and bioactivity evaluation method for drug discovery: T001-10027877 was identified as an antiproliferative agent that targets EGFRT790M/C797S/L858R and EGFRT790M/L858RLinxiao Wang, Xiaoling Huang, Shidi Xu, et al.
Brain, Behavior, and Immunity|August 25, 2025
Alteration of intestinal mucosal immunity and metabolites in mice exposed to chronic restraint stressChujun Duan, Linxiao Wang, Tingting Wang, et al.
European Journal of Medicinal Chemistry|April 7, 2017
Discovery of novel 7-azaindole derivatives bearing dihydropyridazine moiety as c-Met kinase inhibitorsQidong Tang, Linxiao Wang, Yongli Duan, et al.
European Journal of Medicinal Chemistry|May 25, 2023
Design, synthesis and biological evaluation of 4-(4-aminophenoxy)picolinamide derivatives as potential antitumor agentsJintian Dai, Jianqing Zhang, Dongxue Fu, et al.
European Journal of Medicinal Chemistry|December 4, 2017
Synthesis and antiproliferative activity of pyrrolo[2,3-b]pyridine derivatives bearing the 1,8-naphthyridin-2-one moietyQidong Tang, Yongli Duan, Linxiao Wang, et al.
ACS Chemical Neuroscience|June 4, 2025
Tyrosine: A Key Neurotransmitter in Selective Serotonin Reuptake Inhibitor Treatment for Chronic Restraint Stress-Induced Reduction of Intestinal Innate Lymphoid Cell Type 3 CellsYilin Wu, Chujun Duan, Niqi Shan, et al.
Computational Biology and Chemistry|December 24, 2023
T5S1607 identified as a antibacterial FtsZ inhibitor：Virtual screening combined with bioactivity evaluation for the drug discoveryZhouling Xie, Wei Ruan, Jiaojiao Guo, et al.
International Journal of Biological Sciences|January 3, 2024
ADAR1 protects pulmonary macrophages from sepsis-induced pyroptosis and lung injury through miR-21/A20 signalingXiaojun Zhao, Jiangang Xie, Chujun Duan, et al.
Immunobiology|December 19, 2023
ADAR1 regulates macrophage polarization and is protective against liver ischemia and reperfusion injuryLinxiao Wang, Chujun Duan, Xiuhua Wu, et al.
Translational Oncology|November 25, 2023
Non-small cell lung cancer cells with uncommon EGFR exon 19delins variants respond poorly to third-generation EGFR inhibitorsZhiqin Lu, Yali Yi, Linxiao Wang, et al.
Pageof 8